Oxytocin

Generic Name
Oxytocin
Brand Names
Pitocin
Drug Type
Biotech
Chemical Formula
-
CAS Number
50-56-6
Unique Ingredient Identifier
1JQS135EYN
Background

Sir Henry H. Dale first identified oxytocin and its uterine contractile properties in 1906. Like all other neurohypophysial hormones, oxytocin is composed of nine amino acids with a disulfide bridge between the Cys 1 and 6 residues. In the mid-1950s, synthetic oxytocin was successfully synthesized by a biochemist named Vincent du Vigneaud; he was later recog...

Indication

Administration of exogenous oxytocin is indicated in the antepartum period to initiate or improve uterine contractions for vaginal delivery in situations where there is fetal or maternal concern. For example, It may be used to induce labor in cases of Rh sensitization, maternal diabetes, preeclampsia at or near term, and when delivery is indicated due to pre...

Associated Conditions
Incomplete Abortion, Inevitable abortion, Postpartum Bleeding
Associated Therapies
Reinforcement of labor

Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2020-06-23
Last Posted Date
2020-06-23
Lead Sponsor
KU Leuven
Target Recruit Count
64
Registration Number
NCT04443647
Locations
🇧🇪

KU Leuven, Leuven, Belgium

Validate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2020-06-17
Last Posted Date
2024-04-26
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
26
Registration Number
NCT04435704
Locations
🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Apply the PD Model of Peripheral Oxytocin Action to a Multimodal Stimulus

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2020-06-16
Last Posted Date
2024-10-26
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
30
Registration Number
NCT04433741
Locations
🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Generate a Pharmacodynamic Model of Oxytocin for Peripheral Analgesic Effects

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2020-06-16
Last Posted Date
2024-02-28
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
38
Registration Number
NCT04431206
Locations
🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Estimate Serum Oxytocin PD Range in the Periphery

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2020-06-16
Last Posted Date
2022-12-30
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT04431193
Locations
🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

A Study of Oxytocin PK After IV Administration in Healthy Subjects and Advanced Knee Arthritis Subjects

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2020-06-12
Last Posted Date
2022-10-31
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT04429880

Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2020-06-11
Last Posted Date
2024-04-26
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
38
Registration Number
NCT04427709
Locations
🇺🇸

Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Oxytocin Pharmacokinetics After Intramuscular Injection

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2020-06-11
Last Posted Date
2021-04-12
Lead Sponsor
Wake Forest University Health Sciences
Registration Number
NCT04427540

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19

First Posted Date
2020-05-13
Last Posted Date
2021-01-14
Lead Sponsor
Azienda Ospedaliero-Universitaria di Parma
Registration Number
NCT04386447
Locations
🇮🇹

Ospedale San Francesco, Nuoro, Italy

🇮🇹

Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy

🇫🇷

CNRS, Lyon, France

Management of Prelabor Rupture of the Membranes at Term

First Posted Date
2020-03-13
Last Posted Date
2024-04-12
Lead Sponsor
Rambam Health Care Campus
Target Recruit Count
524
Registration Number
NCT04307069
Locations
🇮🇱

Rambam, Ramat Yishai, Israel

© Copyright 2024. All Rights Reserved by MedPath